Section Arrow
ASRT.NASDAQ
- Assertio Holdings
(Financial Status)
Quotes are at least 15-min delayed:2025/12/26 13:43 EST
Regular Hours
Last
 10.1
+0.2015 (+2.04%)
Day High 
10.42 
Prev. Close
9.8985 
1-M High
12 
Volume 
117.95K 
Bid
9.92
Ask
10.3
Day Low
9.5001 
Open
9.68 
1-M Low
9.15 
Market Cap 
63.52M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 10.86 
20-SMA 11.19 
50-SMA 11.54 
52-W High 15.15 
52-W Low 7.7055 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-4.50/0.06
Enterprise Value
103.28M
Balance Sheet
Book Value Per Share
1.10
Cash Flow
Cash Flow Yield
0.21
Income Statement
Total Revenue
124.96M
Operating Revenue Per Share
1.75
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
CGCCanopy Growth Corp1.2275-0.0825-6.30%-- 
HIMSHims & Hers Health34.3675-0.3025-0.87%65.13PE
IXHLIncannex Healthcare0.399199-0.011401-2.78%-- 
TLRYTilray Brands Inc.9.635-0.515-5.07%-- 
UPCUniverse Pharmaceuticals Inc5.02+0.735+17.15%-- 
Industry overview quotes are at least 15 minutes delayed
Business Description
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild tomoderate pain.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.